Thiourea derivatives as activators of RORα and pharmaceutical composition containing same
申请人:Lee Mi Ock
公开号:US10407388B2
公开(公告)日:2019-09-10
Provided is a compound activating RORα gene, particularly a JC1 compound containing CGP52608 thiazolidinedione as a lead substance, and a pharmaceutically acceptable salt thereof. The compound is a lipid accumulation inhibitor and applicable to the treatment of metabolic diseases or inflammatory diseases.
本研究提供了一种激活 RORα 基因的化合物,特别是一种以 CGP52608 噻唑烷二酮为先导物质的 JC1 化合物及其药学上可接受的盐。该化合物是一种脂质蓄积抑制剂,适用于治疗代谢性疾病或炎症性疾病。